Avoidance of Antibiotic Treatment for Acute Bronchitis/ Bronchiolitis (AAB)

HEDIS Measure

Avoidance of Antibiotic Treatment for Acute Bronchitis/ Bronchiolitis (AAB)

Line of business: Commercial Medicaid Medicare

Data Collection Method: Administrative (Claims)

Measure Description

The percentage of episodes for members ages 3 months and older with a diagnosis of acute bronchitis/ bronchiolitis that did not result in an antibiotic dispensing event.

*Inverted measure

Numerator Compliance

Dispensed prescription for an antibiotic medication (AAB Antibiotic Medications List) on or three days after the Episode Date.

Intake period A 12-month window that begins on July 1 of the year prior to the measurement year and ends on June 30 of the measurement year. The intake period captures eligible episodes of treatment.

Episode date The date of service for any outpatient, telephone, observation or ED visit, e-visit or virtual check-in during the intake period with a diagnosis of acute bronchitis/bronchiolitis.

Best Practices

• Reference the Centers for Disease and Control Prevention “Be Antibiotics Aware: Smart Use, Best Care.”

cdc.gov/patientsafety/feastures/be-antibiotics-aware.html

Antibiotic Medications